This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Driven by an older, more diverse population, along with a significant increase in riskfactors including high blood pressure and obesity, total costs related to cardiovasculardisease (CVD) conditions are likely to triple by 2050, according to recent projections. At least 6 in 10 U.S.
ET Tuesday, June 4, 2024 DALLAS, June 4, 2024 — Driven by an older, more diverse population, along with a significant increase in riskfactors including high blood pressure and obesity, total costs related to. Embargoed until 4 a.m.
Every year, the AHA reports the most up-to-date statistics related to heart disease, stroke, and cardiovascularriskfactors. is at an all time high, with 942k cardiovasculardisease-related deaths in 2022, up by 10k from 2021. From 2017 to 2020, adult obesity prevalence in the U.S.
Men with cardiovasculardiseaseriskfactors, including obesity, face brain health decline a decade earlier—from their mid 50s to mid 70s—than similarly affected women who are most susceptible from their mid 60s to mid 70s, suggest the findings of a long term study, published online in the Journal of Neurology Neurosurgery & Psychiatry.
BackgroundObesity is a global epidemic and a major riskfactor for cardiovasculardiseases. This study aims to investigate the impact of weight loss after LSG on the left ventricular myocardial work (LVMW) in obese patients and explore the clinical value of the left ventricular pressure - strain loop (LV - PSL).MethodsThirty
Cardiovasculardisease represents a significant riskfactor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.
Atherosclerosisa key driver of cardiovasculardisease (CVD)continues to be a significant global health issue. The Global Burden of Disease data (2023) highlights a grim reality: while high-income countries have seen some success in managing CVD, LMICs now account for most CVD-related deaths.
We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% to 26.8%) and obesity (43.1% Prevalences of coronary disease (7.8% in 2020 to 61.0% Diabetes (16.3%
Atherosclerosis (ASVD) remains a leading driver of cardiovasculardisease (CVD), a global health challenge that claims millions of lives each year. Explore actionable, evidence-based strategies to combat traditional and emerging riskfactors, with a focus on precision approaches and primordial prevention.
Getty Images milla1cf Fri, 06/28/2024 - 08:10 June 27, 2024 — Cardiovasculardisease is the leading cause of death for women, and gaps in care and access persist between women and men. In 1924, the physicians who founded the American Heart Association believed that better understanding of heart disease would lead to better outcomes.
The 2023 Almanac results derived from the Global Burden of Disease (GBD) and spanning 1990 to 2022, were recently published in the Journal of American College of Cardiology. High systolic blood pressure stands out as a major riskfactor, directly contributing to leading cardiovascular causes of death in LMICs.
Other studies have also unearthed more intricate connections which suggests that physiological conditions, underpinned by biological and chemical factors, may also play a pivotal role in influencing cardiovasculardisease (CVD). In 2021 alone, CVD accounted for over 900,000 deaths in the U.S. and approximately 19.91
For over 50 years, rates of those who are overweight or obese have been rising rapidly. Despite the rise in obesity rates, the growing recognition of it as a global problem and the astronomical sums of money we spend on addressing it, the tide continues to rise. That is until now.
Black History Month is a poignant backdrop to the alarming rise in obesity and type 2 diabetes, particularly among those of marginalized populations. This troubling trend has cemented the 100-year reign of cardiovasculardiseases (CVD) as the #1 killer in America.
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. to 61% of the U.S.
Atherosclerotic cardiovasculardisease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovasculardisease, cognitive impairment, and frailty also share the following riskfactors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
years; p < 0.001), had more cardiovascularriskfactors, target organ damage and cardiovasculardisease (CVD) in comparison with those without hypertension. These patients were older (65.8 ± 10.9 vs. 51.6 ± 14.7 Conclusions About half of patients attended in primary care settings have hypertension in Spain.
Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovasculardisease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD riskfactors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.
Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovasculardisease. White) to assess their CKM stages, finding the following breakdown: Stage 0 (no riskfactors) – 10.6%
Pre-eclampsia and heart failure have common riskfactors, including hypertension, obesity and diabetes. It is not known whether heart failure increases the risk of pre-eclampsia. This study examines whether pregestational heart failure increases the risk of pre-eclampsia.
Cardiovasculardisease (CVD) is the leading cause of death worldwide, accounting for over one-third of all deaths in Singapore. Furthermore, other major riskfactors, such as diabetes mellitus, hypertension, elevated low-density lipoprotein levels, and obesity, are steadily rising. billion USD (11.5 billion SGD).
A growing body of research has identified circadian-rhythm disruption as a riskfactor for metabolic health. These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes.
Overweight and obesity have reached epidemic proportions, affecting more than 70% of the U.S. 1 In addition to numerous health consequences, obesity contributes to cardiovasculardisease indirectly through the development of riskfactors and directly through various biologic mechanisms.2
Obesity, a major riskfactor for cardiovasculardisease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.
Introduction Cardiovasculardiseases (CVDs) are the most important cause of premature death and disability worldwide. The etiological riskfactors of CVDs are widely known and include dyslipidemia, obesity, diabetes, and chronic cigarette consumption.
How Alcohol Affects Heart Function Blood Pressure and Heart DiseaseRisk One of the most significant concerns related to alcohol consumption is its effect on blood pressure. Drinking too much alcohol can lead to high blood pressure, a major riskfactor for heart disease.
Obesity is a major global health issue and a leading cause of premature death. The prevalence of obesity has been rising faster than most other known modifiable riskfactors. In a Global Burden of Disease analysis, the prevalence of obesity was found to have doubled in more than 70 countries from 1980 to 2013.
Cardiovasculardisease (CVD) is a critical public health concern, with riskfactors such as high blood pressure, abnormal blood sugar levels, elevated cholesterol, and obesity beginning in childhood.
Aims:Asian Americans experience disproportionate burdens of cardiovascularriskfactors and cardiovasculardisease (CVD). However, the trends in cardiovascularrisks in adults from different Asian ethnic backgrounds remain understudied. p< 0.001) and alcohol use (AAPC: 2.3%,p<
Non-alcoholic fatty liver disease (NAFLD), now known as metabolic-associated steatotic liver disease (MASLD), is the most common liver disease worldwide, with a prevalence of 38%. In these patients, cardiovasculardisease (CVD) is the number one cause of mortality rather than liver disease.
When it comes to cardiovasculardisease, two of the biggest riskfactors we must consider are: ApoB concentration - A measure of the number of circulating lipid particles. The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heart attack 2.
Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major riskfactor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.
Obesity is a global pandemic and is a recognised riskfactor for cardiovasculardiseases. Body surface area and body mass index were important anthropometric features that correlated with the above echocardiographic changes, and should be routinely evaluated to assess cardiovascularrisk in patients.
An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovasculardisease, and this prevalence is unchanged over time. said Michael Miedema, MD, MPH , director of the Nolan Family Center for Cardiovascular Health at MHIF and senior author of the research.
Cardiovasculardiseases (CVD) are the leading cause of mortality and morbidity worldwide. However, imbalances in these elements are linked to cardiovascular disturbances. Thus, this study aimed to investigate the association between circulating levels of Zn, Cu, and Zn/Cu ratio with CVD riskfactors in the Qatari population.
Here’s what you can expect at the biggest conference in cardiorenal metabolic health, the 19th Annual Cardiometabolic Congress (CMHC), DECODING THE CONSTELLATION of Cardiometabolic Health and RiskFactors. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.
kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). kg/m2), normal weight (18.524 kg/m2), overweight (2428 kg/m2), and obese (>28 kg/m2). The primary outcome was inhospital allcause mortality. The highest mortality rate was observed in the group who were SMuRFless and underweight (3.5%).
Primordial prevention is changing the environment around you so you do not develop the riskfactors for heart disease and, by extension, do not get the disease early in life. New obesity medications such as GLP-1 agonists have shown significant reductions in weight in those with a prior heart attack. N Engl J Med.
Ballantyne, MD , emphasized that while fellows may consider prevention “boring,” it is crucial for avoiding resource-intensive late-stage cardiovasculardisease (CVD). He highlighted that cardiovascular health is essential for cognitive health, noting the common occurrence of vascular dementia.
BACKGROUND:The relationship between marijuana use and cardiovascular health remains uncertain, with several observational studies suggesting a potential association with increased adverse atherosclerotic cardiovasculardisease (ASCVD) outcomes. P=0.84), obesity (35.8% Likewise, mean 10-year ASCVD risk scores (2.8%
As we get older, the risk of dementia increases for everyone, regardless of riskfactor control. Poor Sleep Is A Major RiskFactor For Insulin Resistance. Insulin resistance is a significant driver of cardiovascularrisk. Obesity is one of the biggest global health concerns we face today.
BackgroundAsian people in the United States have different sociodemographic and health‐related characteristics that might affect cardiovasculardisease (CVD) risk by ethnicity and birthplace. Providers should consider this heterogeneity in CVD riskfactors and establish tailored CVD prevention plans for Asian subgroups.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content